Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Hpc Biosciences
Join Channel
Consolidated Standalone

HPC Biosciences

₹26.2 0 | 0%

Market Cap ₹418 Cr.

Stock P/E 671.8

P/B 12.7

Current Price ₹26.2

Book Value ₹ 2.1

Face Value 1

52W High ₹0

Dividend Yield 0%

52W Low ₹ 0

Edit Ratio

HPC Biosciences Research see more...

Overview Inc. Year: 2002Industry: Agriculture

HPC Biosciences Ltd is a biotechnology company that focuses on the discovery and development of innovative drugs for the treatment of various diseases. The company specializes in the fields of oncology, immunology, and inflammation, using advanced technologies and scientific expertise to develop small molecule therapeutics and biologics. HPC Biosciences is committed to advancing the development of novel drug candidates by conducting rigorous research, leveraging strategic partnerships, and utilizing cutting-edge technologies. The company's portfolio includes several drug candidates that are in various stages of preclinical and clinical development. Overall, HPC Biosciences is dedicated to improving patient outcomes and advancing the field of biotechnology through innovative drug discovery and development.

Read More..

HPC Biosciences Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

HPC Biosciences Quarterly Results

#(Fig in Cr.) Sep 2013 Sep 2016 Sep 2017
Net Sales 1 1 1
Other Income 0 0 0
Total Income 1 1 1
Total Expenditure -0 0 0
Operating Profit 1 1 1
Interest 0 0 0
Depreciation 1 0 0
Exceptional Income / Expenses 0 0 0
Profit Before Tax 0 0 0
Provision for Tax 0 0 0
Profit After Tax 0 0 0
Adjustments -0 -0 -0
Profit After Adjustments 0 0 0
Adjusted Earnings Per Share 0 0 0

HPC Biosciences Profit & Loss

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 TTM
Net Sales 0 3 5 3 3 2 2 2 2 1 2 3
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 0 3 5 4 3 2 2 2 2 1 2 3
Total Expenditure 0 -0 0 1 1 0 1 1 0 0 1 0
Operating Profit -0 3 4 3 2 2 2 1 1 1 2 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 3 3 1 1 1 1 0 1 0 1 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 3 3 1 1 0 1 0 1 0 1 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 3 3 1 1 0 1 0 1 0 1 0
Adjusted Earnings Per Share -0 0.9 0.2 0.1 0 0 0 0 0 0 0.1 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 100% 0% 0% 0%
Operating Profit CAGR 100% 26% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 0% -0% -3% -7%
ROE Average 4% 2% 2% 15%
ROCE Average 4% 2% 2% 15%

HPC Biosciences Balance Sheet

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Shareholder's Funds 0 5 28 29 30 30 31 31 31 32 33
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 0 0 0 0 0 0 0 0 1 0 0
Total Liabilities 0 5 28 29 30 30 31 31 32 32 33
Fixed Assets 0 1 11 10 8 7 6 5 4 4 3
Other Non-Current Assets 0 0 6 6 4 4 4 4 4 4 4
Total Current Assets 0 4 11 13 17 19 21 22 24 25 26
Total Assets 0 5 28 29 30 30 31 31 32 32 33

HPC Biosciences Cash Flow

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Opening Cash & Cash Equivalents 0 0 0 1 0 1 1 0 0 0 0
Cash Flow from Operating Activities -0 -0 3 4 0 -0 1 0 1 1 1
Cash Flow from Investing Activities 0 -1 -23 -5 1 0 -2 -0 -1 -1 0
Cash Flow from Financing Activities 0 2 20 0 -0 0 0 0 0 0 0
Net Cash Inflow / Outflow -0 0 1 -0 0 -0 -1 -0 0 0 1
Closing Cash & Cash Equivalent 0 0 1 0 1 1 0 0 0 0 2

HPC Biosciences Ratios

# Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Earnings Per Share (Rs) -0.01 0.87 0.19 0.08 0.04 0.03 0.03 0.01 0.03 0.02 0.07
CEPS(Rs) -0.01 0.91 0.27 0.16 0.13 0.12 0.09 0.07 0.08 0.06 0.11
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.49 1.37 1.72 1.79 1.84 1.87 1.91 1.93 1.96 1.99 2.06
Core EBITDA Margin(%) 0 109.61 90.31 73.68 64.61 93.83 60.86 48.54 75.32 72.26 70.83
EBIT Margin(%) 0 105.16 62.57 36.29 24.46 27.44 25.2 12.33 36.17 29.94 52.14
Pre Tax Margin(%) 0 105.16 62.57 36.28 24.45 27 25.03 11.9 36.07 29.92 52.12
PAT Margin (%) 0 105.16 62.52 35.7 22.78 24.65 22.48 10.12 34.63 28.06 51.16
Cash Profit Margin (%) 0 109.61 90.41 74.96 68.41 98.64 66.39 53.41 79.37 78.87 73.59
ROA(%) -0.6 124.91 18.25 4.32 2.39 1.54 1.66 0.63 1.75 1.05 3.58
ROE(%) -1.02 125.8 18.47 4.41 2.44 1.56 1.68 0.64 1.78 1.07 3.62
ROCE(%) -0.61 124.95 18.43 4.45 2.6 1.73 1.88 0.78 1.86 1.14 3.69
Receivable days 0 43.8 55.17 0 233.6 512.37 577.12 848.13 1192.36 1630.41 888.1
Inventory Days 0 97.88 69.61 98.08 87.85 188.39 200.57 201.1 205.59 256.43 107.96
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 0 22 679.59 1040.72 1446.37 1526.73 3296.75 0 0 0
Price/Book(x) 0 0 2.39 29.38 25.06 22.33 25.4 21.03 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0 0.57 13.63 242.49 236.97 356.75 343.1 332.72 9.81 13.06 6.85
EV/Core EBITDA(x) -147.6 0.52 15.07 321.01 338.13 351.75 496.53 598.21 12.12 16.17 9.19
Net Sales Growth(%) 0 0 64.32 -27.31 -10.61 -39.64 20.91 -13.87 -17.73 -25.03 90.55
EBIT Growth(%) -150 0 -2.23 -57.85 -39.74 -32.3 11.04 -57.85 141.33 -37.95 231.87
PAT Growth(%) -150 0 -2.31 -58.49 -42.95 -34.69 10.27 -61.22 181.45 -39.26 247.42
EPS Growth(%) -150 0 -78.58 -58.51 -42.89 -34.62 10.03 -61.32 182.31 -39.23 247.39
Debt/Equity(x) 0.68 0 0 0.01 0 0 0 0 0 0 0
Current Ratio(x) 98.4 7394.4 76.31 27.43 219.48 192.77 52.59 47.41 42.49 53.95 92.99
Quick Ratio(x) 98.4 5840 69 25.7 210.98 180.16 49.55 45.46 40.91 52.19 91.04
Interest Cover(x) 0 0 7949.78 3936.3 3272.56 63.08 150.94 28.83 369.11 1956.75 2897.08
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

HPC Biosciences Shareholding Pattern

# Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
Promoter 21.93 21.93 21.93 21.93 21.93 21.93 21.93 21.93 21.93 21.93
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 78.07 78.07 78.07 78.07 78.07 78.07 78.07 78.07 78.07 78.07
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 21.93%.
  • Company has a low return on equity of 2% over the last 3 years.
  • Stock is trading at 12.7 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

HPC Biosciences News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!